Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
RSV, Flu and COVID-19 season is here, so do you need three vaccines?
COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you may be wondering -- which do you need and can you get them at the same time?
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% effective in preventing severe illness three years after patients 60 and older first received the shot.
What to know about the RSV vaccine ahead of virus season
Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people she said are most vulnerable to the disease.
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are already huge inequities in access and uptake.
RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
In recent years, however, COVID-19 has not only stolen the public health spotlight but also eclipsed the development of the first RSV vaccine. Vaccine uptake may not be much better during the 2024–25 respiratory virus season.
Yahoo
2d
New RSV vaccine guidelines: Adults 75+ urged to vaccinate
AUSTIN (KXAN) — In 2023, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) ...
5d
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Acsh.org
4d
The First-Ever Antiviral Treatment for RSV?
EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...
WSLS 10
3d
RSV: A Growing Threat Beyond Children, Experts Advise Vaccination
Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...
KCAU Sioux City on MSN
1d
New ‘revolutionary’ treatment can protect your baby from RSV
Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...
FierceBiotech
5d
'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
6d
GSK RSV shot 43% effective against severe disease in third year
GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...
scrippsnews on MSN
3d
Harnessing Your Health: What you need to know about COVID-19, flu, and RSV for the fall and winter
There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...
News Medical on MSN
1d
Research links NK cells to severe cases of RSV in children
Respiratory syncytial virus (RSV) is the leading cause of hospitalization in young children due to respiratory complications such as bronchiolitis and pneumonia.
Bedford Today on MSN
5h
Bedfordshire residents are encouraged to get 'winter ready' with flu and Covid jabs - plus new RSV vaccination
It’s that time of year again when those most at risk of getting seriously ill from flu and Covid should sign up for their ...
WPMI Mobile on MSN
3d
Doctors recommend pregnant women receive RSV vaccine to help protect infants
As we enter cold and flu season, the medical community wants pregnant women to know it's now recommended they receive the RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
COVID
GSK
United States
Human respiratory syncytial virus
GlaxoSmithKline
Feedback